Xl Laboratories Private Limited, a active private limited company, was established on 16 March 2000 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239DL2000PTC104513. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.
It upholds a compliant status. Employing 370 professional, Its leadership includes Rahul Bhargava (Director), Ashok Kumar Bhargava (Director). Past directors included Pradeep Bhargava. It holds ₹13.78 Cr open charges and ₹12.60 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Dsm 430-431 Dlf Tower Shivaji Marg, New Delhi, Delhi, 110015.
U24239DL2000PTC104513
104513
16 March 2000
₹3.00 Cr
₹3.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Xl Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Bhargava | Director | 16 Mar 2002 | Current |
| Ashok Kumar Bhargava | Director | 11 Feb 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Jan 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Xl Laboratories Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 35.79% increase. The company also saw a substantial improvement in profitability, with a 1121.08% increase in profit. The company's net worth Soared by an impressive increase of 23.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Xl Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹137,800,000.00
₹125,965,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Mar 2025 | Indian Overseas Bank | ₹1.45 Cr | Open |
| 16 Nov 2024 | Others | ₹5.00 Cr | Open |
| 23 Sep 2024 | Others | ₹3.50 M | Open |
| 04 May 2024 | Others | ₹5.80 M | Open |
| 27 Nov 2020 | Others | ₹4.10 Cr | Open |
Explore comprehensive loan charge details -
Xl Laboratories has a workforce of 370 employees as of Oct 14, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Xl Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xl Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Indian Overseas Bank amounted to Rs. 1.45 Cr with Charge ID 101076332 was registered on 17 Mar 2025. was completed.
Progress on A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101002688 was registered on 16 Nov 2024. was documented.
Progress on Xl Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Others amounted to Rs. 0.35 Cr with Charge ID 100988199 was registered on 23 Sep 2024. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.58 Cr with Charge ID 100937211 was registered on 04 May 2024. was completed.
Progress on Xl Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The CIN of Xl Laboratories Private Limited is U24239DL2000PTC104513.
Xl Laboratories Private Limited is headquartered at Dsm 430-431 Dlf Tower Shivaji Marg, New Delhi, Delhi, 110015.
Xl Laboratories Private Limited was incorporated on 16 March 2000.
The current directors of Xl Laboratories Private Limited are
The primary industry of Xl Laboratories Private Limited is Manufacturing.
Xl Laboratories Private Limited is unlisted.
The authorized capital of Xl Laboratories Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.
The compliance status of Xl Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX